Targeting HDACs in Pancreatic Neuroendocrine Tumor Models

Targeting HDACs in Pancreatic Neuroendocrine Tumor Models

Compared to pancreatic adenocarcinoma (PDAC), pancreatic neuroendocrine tumors (PanNET) represent a rare and heterogeneous tumor entity. In addition to surgical resection, several therapeutic approaches, including biotherapy, targeted therapy or chemotherapy are applicable. However, primary or secon...

Full description

Bibliographic Details
Main Authors: Rosa Lynn Schmitz, Julia Weissbach, Jan Kleilein, Jessica Bell, Stefan Hüttelmaier, Fabrice Viol, Till Clauditz, Patricia Grabowski, Helmut Laumen, Jonas Rosendahl, Patrick Michl, Jörg Schrader, Sebastian Krug
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Cells
Subjects:
neuroendocrine
pancreas
PanNET
HDAC
panobinostat
Online Access:https://www.mdpi.com/2073-4409/10/6/1408

Similar Items

Similar Items